BMSD : 10.65048
BMSD : 10.65048
https://doi.org/10.65048/ijbmr
Search
About Us
Authors
Reviewers
Editorial Board
Contact Us

Exploring the fibrinolytic and biochemical characteristics of lumbrokinase enzyme from eudrilus eugeniae for therapeutic use

Authors:Shashank. K. R* and Mahadevaswamy. M
Int J Biol Med Res. 2026; 17(1): 8297-8301  |  PDF File  |  Full Text
DOI No.: 10.65048/ijbmr.2026.17.1.8297.1001

Abstract

The study aimed to isolate, purify, and characterize lumbrikinase from Eudrilus eugeniae using a comprehensive biochemical and analytical approach, with the objective of evaluating its fibrinolytic activity and therapeutic potential of Lumbrikinase, a potent fibrinolytic enzyme extracted from earthworms, has attracted considerable interest due to its thrombolytic and cardiovascular therapeutic applications. Despite its importance, systematic biochemical characterization from E. eugeniae remains limited, necessitating detailed purification and evaluation studies.Earthworm homogenates were subjected to ammonium sulfate precipitation, followed by purification through ion-exchange chromatography using DEAE-cellulose and gel filtration chromatography with Sephadex G-100. Fibrinolytic activity was determined using the fibrin plate method. The purified enzyme was analyzed by SDS-PAGE and fibrin zymography. Enzyme kinetics were assessed using Lineweaver–Burk plots. Stability studies were conducted to evaluate activity across varying pH and temperature conditions.Fibrin plate assays demonstrated progressive enhancement of lytic zones with purification, indicating increased enzyme specificity and activity. SDS-PAGE and fibrin zymography confirmed the presence of a prominent active protein band at ~27.5 kDa. Kinetic analysis yielded a Km of 0.9 mg/mL and Vmax of 160 µmol/min/mg for fibrin, suggesting strong substrate affinity and high catalytic efficiency. The enzyme exhibited optimal activity at pH 7.5 and 37°C, with significant stability and retention of activity under physiological conditions.The purified lumbrikinase from E. eugeniae displays substantial thrombolytic capability, with favorable stability and kinetic properties, underscoring its potential application in cardiovascular therapeutics. This comprehensive characterization provides a strong foundation for future studies on clinical applications, formulation, and molecular investigations of the enzyme.